repair 01
Fortigel® collagen peptides
Randomised trial in physically active adults · randomised, placebo-controlled · n not published · 12 weeks
Lower activity-related joint discomfort when walking, climbing stairs and squatting.
The trial dose was 5 g/day; the tablet delivers 1 g, so we do not transfer that result to this dose. We tell you that.
Evidence level 3/5 · published randomised clinical trial
repair 01
Ovomet® egg membrane
Placebo-controlled human trials at 300 mg/day · randomised, placebo-controlled · n not published · 4 to 8 weeks
Reduction in joint pain and stiffness.
Evidence level 3/5 · published randomised clinical trial
repair 01
Vitamin C
EU Register of nutrition and health claims · Regulation (EU) No 432/2012 · authorised EU health claim · not applicable · not applicable
Vitamin C contributes to normal collagen formation for the normal function of cartilage and bones.
Evidence level 4/5 · several trials or authorised claim
renew 02
Verisol® collagen peptides
Proksch et al., Skin Pharmacology and Physiology, 2014 · randomised, double-blind, placebo-controlled · n = 114 women aged 45–65 · 8 weeks
Reduced eye-wrinkle volume and increased type I procollagen versus placebo.
Trial dose 2.5 g/day; the tablet delivers 1 g.
Evidence level 3/5 · published randomised clinical trial
renew 02
Ovoderm® egg membrane
Human skin elasticity and barrier trial at 300 mg/day · randomised, double-blind, placebo-controlled · n = 50 · 60 days
Improved skin elasticity and barrier function.
Ovoderm® is an authorised novel food in the EU (2026), maximum 500 mg/day.
Evidence level 3/5 · published randomised clinical trial
renew 02
Zinc and biotin
EU Register of nutrition and health claims · Regulation (EU) No 432/2012 · authorised EU health claim · not applicable · not applicable
Zinc and biotin contribute to the maintenance of normal skin and hair; zinc also contributes to the maintenance of normal nails.
Evidence level 4/5 · several trials or authorised claim
reset 03
Nextida® GC
Single-meal post-prandial glucose trial · crossover, placebo-controlled · n not published · single-meal design
Lower post-prandial glucose peak versus control.
Acute effect on one meal; not a weight-loss trial.
Evidence level 2/5 · pilot or manufacturer trial
reset 03
Acacia fibre
Published literature on soluble fibre and satiety · evidence across the fibre class · n not published · variable duration
General evidence on soluble fibre and satiety.
Evidence level 3/5 · published randomised clinical trial
reset 03
Chromium
EU Register of nutrition and health claims · Regulation (EU) No 432/2012 · authorised EU health claim · not applicable · not applicable
Chromium contributes to normal macronutrient metabolism and to the maintenance of normal blood glucose levels.
Evidence level 4/5 · several trials or authorised claim
rise 04
PeptiStrong®
BMJ Nutrition, Prevention & Health · randomised, double-blind, placebo-controlled · n not published · duration not published on this page
Greater strength and less strength loss after eccentric exercise versus placebo.
Trial dose 2.4 g/day; the tablet delivers 1.2 g.
Evidence level 3/5 · published randomised clinical trial
rise 04
Creatine monohydrate
Hundreds of trials and ISSN position stand · scientific consensus · n across hundreds of trials · multiple durations
Increases strength and lean mass with training.
The EU claim requires 3 g/day; at 1.5 g we make no claim.
Evidence level 5/5 · scientific consensus
rise 04
Magnesium
EU Register of nutrition and health claims · Regulation (EU) No 432/2012 · authorised EU health claim · not applicable · not applicable
Magnesium contributes to normal muscle function, normal protein synthesis and a reduction of tiredness and fatigue.
Evidence level 4/5 · several trials or authorised claim
mind 05
PeptiSleep®
Manufacturer's placebo-controlled trial · manufacturer placebo-controlled trial · n not published · duration not published on this page
More minutes of sleep per night reported by the manufacturer.
We say so: it is a manufacturer trial, and it is what exists.
Evidence level 2/5 · pilot or manufacturer trial
mind 05
Glycine
Small randomised sleep trials · randomised trials · n not published · short-term trials
Improved subjective sleep quality and next-day fatigue at 3 g before bed.
Level 3 for the trial dose; the tablet delivers 1 g.
Evidence level 3/5 · published randomised clinical trial
mind 05
L-theanine
Randomised trials at 200 mg · randomised trials · n not published · variable duration
Reduced stress response without sedation.
Evidence level 3/5 · published randomised clinical trial
mind 05
Magnesium
EU Register of nutrition and health claims · Regulation (EU) No 432/2012 · authorised EU health claim · not applicable · not applicable
Magnesium contributes to normal psychological function, normal functioning of the nervous system and a reduction of tiredness and fatigue.
Evidence level 4/5 · several trials or authorised claim